PolyPid Ltd.

The momentum for this stock is not very good. Tradey thinks it is not wise to invest in PolyPid Ltd..

News

PolyPid to Participate in Three Upcoming Fall Investor Conferences

Globe Newswire PETACH TIKVA,Israel, Sept. 03, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), ( PolyPid or the Company ), a late-stage biopharma company aiming to improve surgical outcomes, today...\n more…

PolyPid files to sell 3.91M ordinary shares for holders

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Head-To-Head Review: PolyPid (NASDAQ:PYPD) and LENSAR (NASDAQ:LNSR)

Zolmax PolyPid (NASDAQ:PYPD - Get Free Report) and LENSAR (NASDAQ:LNSR - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on...\n more…

Comparing PolyPid (NASDAQ:PYPD) & LENSAR (NASDAQ:LNSR)

Ticker Report LENSAR (NASDAQ:LNSR - Get Free Report) and PolyPid (NASDAQ:PYPD - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based...\n more…

PolyPid Ltd. (NASDAQ:PYPD) Short Interest Up 68.0% in August

Ticker Report PolyPid Ltd. (NASDAQ:PYPD - Get Free Report) was the recipient of a large increase in short interest in August. As of August 15th, there was short interest totalling 4,200 shares, an increase of...\n more…

Equities Analysts Offer Predictions for PolyPid Ltd.'s Q3 2024 Earnings (NASDAQ:PYPD)

Ticker Report PolyPid Ltd. (NASDAQ:PYPD - Free Report) - Stock analysts at HC Wainwright boosted their Q3 2024 earnings estimates for PolyPid in a research report issued to clients and investors on Thursday...\n more…